For a broader look at simple performance-focused formulas, explore our Boosts collection
Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis
It is water-extracted and minimally processed, providing a 'clean, naturally sourced, and transparent caffeine option
Our most advanced candidate, danuglipron, has shown good efficacy in a twice-daily formulation, and we believe a once-daily formulation could be highly competitive in the oral GLP-1 space, said Mikael Dolsten, MD., PhD., Chief Scientific Officer & President, Pfizer Research and Development
It is most commonly submitted for patients with iron deficiency anemia who cannot absorb oral iron, and for chronic kidney disease patients on hemodialysis receiving IV iron alongside ESA therapy